Oraya Therapeutics
Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.
3
Funding Rounds
$64.0m
Money raised
Overview
Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Oraya Therapeutics has raised a total of $64m in funding over 3 rounds.
Key Insights:
- Oraya Therapeutics Series C round: $42m
- Oraya Therapeutics Series B round: $18m
- Oraya Therapeutics Series A round: $4m
Oraya Therapeutics Series C round
$42m
Oraya Therapeutics Series B round
$18m
Oraya Therapeutics Series A round
$4m
Industries
Oraya Therapeutics is active in the following industries: